In a recent ruling, the United States Court of Federal Claims dismissed a petition from Sharon Bailey, who claimed that an influenza vaccine caused her to develop Guillain-Barré syndrome (GBS). The court found that Bailey did not provide sufficient evidence to support her claim. This decision is significant as it highlights the challenges individuals face when seeking compensation under the National Vaccine Injury Compensation Program.
The case, Bailey v. Secretary of Health and Human Services, was filed under docket number 22-0070V. It was overseen by Special Master Christian J. Moran, who issued the ruling on October 13, 2026. The outcome impacts not only Bailey but also others who may seek compensation for vaccine-related injuries.
Background
Sharon Bailey filed her initial petition on January 24, 2022, alleging that the influenza vaccine she received on September 2, 2020, caused her to develop GBS. GBS is a rare neurological disorder that can cause muscle weakness and paralysis. Bailey amended her petition on May 31, 2023, to further detail her claims.
The Secretary of Health and Human Services, represented by the Department of Justice, recommended against compensation. They disputed both the diagnosis of GBS and whether her symptoms began within the time frame established by the National Vaccine Injury Compensation Program’s guidelines.
The case progressed with expert reports from both sides. Bailey submitted a report from Dr. David Simpson, who suggested that her back pain, which began shortly after vaccination, was unrelated to her later GBS symptoms. Conversely, the Secretary provided a report from Dr. Robert Naismith, who agreed with the GBS diagnosis but argued that the timeline did not support a causal link to the vaccine.
The Ruling
The court ruled in favor of the Secretary, concluding that Bailey's GBS symptoms began within two days of her vaccination, which fell short of the required three-day minimum for establishing a presumption of causation under the National Vaccine Injury Compensation Program. The opinion stated, "The evidence preponderates in favor of finding that Ms. Bailey’s GBS began within two days of her September 2, 2020 vaccination."
Special Master Moran noted that Bailey's medical records indicated her back pain began shortly after the vaccination and was associated with the onset of her GBS. The court found that the early back pain was likely a manifestation of GBS rather than a separate issue. The ruling emphasized that Bailey did not meet the necessary evidentiary standards to prove that her condition was caused by the vaccine.
Ultimately, the court dismissed Bailey's case with prejudice, meaning she cannot refile the same claim in the future. The ruling stated, "Thus, this case is DISMISSED WITH PREJUDICE for insufficient proof." This decision underscores the importance of providing robust medical evidence in vaccine injury claims.
Impact
This ruling has broader implications for individuals seeking compensation for vaccine-related injuries. The court's decision illustrates the stringent requirements petitioners must meet to establish a causal link between a vaccine and an injury. The National Vaccine Injury Compensation Program is designed to provide compensation for individuals injured by vaccines, but it requires compelling medical evidence to support claims.
Bailey's case serves as a reminder that while the program exists to help those injured by vaccines, the burden of proof lies heavily on the petitioner. This ruling may deter some potential claimants who may feel discouraged by the high standards of evidence required to succeed in such cases.
What's Next
Bailey has indicated her intention to preserve her ability to pursue a civil action, despite the dismissal of her petition. It remains unclear if she will proceed with a new claim or seek other legal avenues. Additionally, the ruling can be appealed, but details about any potential appeal were not available in the court filing.
